Skip to content
PubMed This is a summary of 26 peer-reviewed journal articles Updated
Radiology

What Is a Delayed-Contrast Inner-Ear MRI, and Is It Safe?

At a Glance

A delayed-contrast inner-ear MRI uses timed images after MRI contrast to look for enlarged endolymphatic spaces, called endolymphatic hydrops. It is generally safe after screening, but implants, kidney disease, pregnancy, prior reactions, and claustrophobia may affect planning.

A delayed-contrast inner-ear MRI is a specialized imaging test used to visualize the fluid spaces inside your inner ear. It involves administering a gadolinium-based contrast agent (MRI contrast), waiting a specific number of hours for the agent to enter the inner ear, and then taking high-resolution images. MRI uses a strong magnetic field rather than ionizing radiation [1].

The inner ear contains two main fluid compartments: the perilymph and the endolymph. The contrast agent enhances the perilymph, creating a signal difference between it and the unenhanced endolymph. This allows radiologists to evaluate whether the endolymphatic space is enlarged—a condition known as endolymphatic hydrops [2][1].

How the Contrast is Given: IV vs. Intratympanic

The contrast agent can be administered in two ways, which determines the timing and logistics of your test:

  • Intravenous (IV) Contrast: This is the most common method. Contrast is injected into a vein in your arm, which usually causes only brief needle discomfort. Because it takes time for the agent to travel through your bloodstream into the inner ear, you will typically wait about 4 hours between the injection and the scan [2]. You may be able to leave the facility and return during this wait. Some optimized imaging protocols might shorten this interval to 2 hours [3]. IV contrast allows doctors to examine both ears simultaneously [4].
  • Intratympanic (IT) Contrast: A specialist doctor injects diluted contrast directly through an artificially perforated eardrum into the middle ear [5]. The MRI is typically performed 24 hours later [2]. While this method can provide stronger local enhancement in the treated ear [6], it is generally an off-label procedure performed at specialized centers, and evaluates only one ear at a time [4]. IT contrast is an ear procedure that can cause temporary pain, pressure, or brief vertigo, and carries uncommon risks like persistent eardrum perforation, infection, or temporary hearing changes [7][5][8].

What Happens During the Scan?

Once it is time for the scan, you will lie on the bed of an MRI machine. These scans are often preferred or performed on 3-Tesla (3T) MRI machines because their stronger magnetic field helps capture the necessary high-resolution images, though some centers may use 1.5T scanners with optimized protocols [2].

  • Positioning: A special piece of equipment called a “head coil” will be placed around your head to capture the imaging signals [9]. You must remain perfectly still, as movement can blur the highly detailed images.
  • Noise and Duration: The actual imaging usually takes 8 to 15 minutes [9]. However, MRI machines produce loud knocking and buzzing noises; you will be given earplugs or specialized headphones. The total time spent at the facility will be much longer than the scan itself.
  • Claustrophobia: Because the head coil is close to your face and the MRI tube is enclosed, claustrophobia is a common challenge. If you are prone to claustrophobia, discuss this with your doctor beforehand. Some facilities can prescribe a medically appropriate sedative, but you will need an escort to drive you home and monitor you afterward. Note that while “open-bore” scanners exist, they may not always have the necessary field strength or capability for this specific high-resolution inner-ear protocol [10].

Safety and Contraindications

Delayed-contrast MRIs are generally safe, but require specific medical screening before you can be scanned:

  • Metal and Implant Screening: Because MRI uses powerful magnets, you must disclose all implanted devices, pacemakers, cochlear implants, aneurysm clips, metal fragments (especially in the eye), or prior metal injuries. The MRI team—not the patient—must verify the exact make and model of your implants to determine if they are safe to scan. This is especially important for inner-ear patients who may have hearing implants.
  • Kidney Disease: In the past, gadolinium contrast was strictly avoided in patients with severe chronic kidney disease (CKD) due to a rare but serious condition called nephrogenic systemic fibrosis (NSF) [11]. Modern “Group II” gadolinium agents carry an extremely low risk of NSF, but the decision to use contrast should still be individualized based on your current kidney function and clinical need [12][13].
  • Prior Contrast Reactions: Allergic-like reactions to gadolinium are uncommon. If you have asthma, multiple allergies, or have reacted to MRI contrast in the past, your doctor may use a different contrast agent or provide pre-medications, though this does not guarantee a reaction will not recur [14][15].
  • Pregnancy and Breastfeeding: Gadolinium contrast is generally avoided during pregnancy unless the expected clinical benefit outweighs the uncertain risks to the fetus [16][17]. If you are breastfeeding, current medical consensus indicates that the amount transferred to breast milk is incredibly small, and reflexively stopping breastfeeding is generally considered unwarranted [18].

Understanding the Results

Specialized MRI sequences (such as 3D-FLAIR or 3D-real IR) can detect and grade the severity of endolymphatic hydrops [1]. However, accuracy varies depending on the scanner, protocol, and radiologist interpreting the scan [19].

An MRI report showing hydrops does not automatically mean you have Ménière’s disease [20][21]. Hydrops can be present in people with vestibular migraine, other inner-ear conditions, or even healthy individuals with no symptoms [20]. Also, the severity of hydrops seen on the scan does not reliably predict how frequent or severe your vertigo attacks will be [21][22]. Conversely, a negative scan does not invalidate your symptoms; some patients with classic Ménière’s symptoms have normal MRIs [21].

Ménière’s disease is a clinical diagnosis based on a specific history of spontaneous vertigo attacks (including their duration and pattern), audiometrically documented fluctuating sensorineural hearing loss, tinnitus, and ear fullness, while ruling out other causes [23][24]. The MRI is a tool to support your evaluation, but treatment is not determined by the hydrops image alone [25]. Additionally, you should ask your doctor if this specialized hydrops scan also includes the conventional sequences needed to rule out other structural issues, like vestibular schwannoma, or if a separate MRI protocol is required [26].

Common questions in this guide

What does a delayed-contrast inner-ear MRI look for?
It looks for endolymphatic hydrops, an enlargement of the endolymph-filled space in the inner ear. Timed MRI contrast makes the fluid compartments look different on high-resolution images, helping the radiologist assess both ears.
Is a delayed-contrast inner-ear MRI generally safe?
Generally, yes. MRI itself uses a magnetic field rather than ionizing radiation, but the imaging team must screen for unsafe implants and review kidney function, pregnancy, and previous contrast reactions before giving MRI contrast.
How long do I wait between contrast and the inner-ear MRI?
With intravenous contrast, the scan is commonly performed about four hours after injection, although some protocols use about two hours. Intratympanic contrast usually requires a middle-ear injection and imaging about 24 hours later; it can cause temporary pain, pressure, or vertigo.
Can an inner-ear hydrops MRI diagnose Ménière’s disease?
No. Hydrops can occur with Ménière’s disease, vestibular migraine, other inner-ear conditions, or even without symptoms, so diagnosis depends on your history, hearing tests, and evaluation for other causes. A normal scan also does not rule out Ménière’s disease.
What should I know if I have kidney disease or am pregnant?
Tell your doctor and the imaging team before the scan. People with severe kidney disease may need an individualized assessment of the contrast decision, and gadolinium is generally avoided during pregnancy unless the expected benefit outweighs uncertain fetal risks.
What if I am claustrophobic or need medication to get through the scan?
Tell the imaging center before your appointment. The image-taking portion often lasts about 8 to 15 minutes, but a sedative may require a prescription, an escort, and someone to drive you home; an open-bore scanner may not support this specialized protocol.
Will this MRI also check for a vestibular schwannoma?
Not necessarily. Ask whether the ordered protocol includes the conventional MRI sequences used to look for other structural problems, or whether a separate MRI protocol is needed.

Get notified when new evidence is published on endolymphatic hydrops.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (26)
  1. 1

    Prospective MR Evaluation of Endolymphatic Hydrops at Multiple Flip Angles Using Single-Dose Gadolinium Contrast.

    Pham N, Kullar P, Fischbein N, et al.

    AJNR. American journal of neuroradiology 2025; (46(12)):2599-2609 doi:10.3174/ajnr.A8880.

    PMID: 41298110
  2. 2

    A systematic review on delayed acquisition of post-gadolinium magnetic resonance imaging in Ménière's disease: imaging of the endolymphatic spaces.

    Han A, Kontorinis G

    The Journal of laryngology and otology 2023; (137(3)):239-245 doi:10.1017/S0022215122001347.

    PMID: 35674257
  3. 3

    Optimized 3D-FLAIR sequences to shorten the delay between intravenous administration of gadolinium and MRI acquisition in patients with Menière's disease.

    Barlet J, Vaussy A, Ejzenberg Y, et al.

    European radiology 2022; (32(10)):6900-6909 doi:10.1007/s00330-022-08889-y.

    PMID: 35759015
  4. 4

    Imaging of Ménière Disease.

    Bernaerts A, De Foer B

    Neuroimaging clinics of North America 2019; (29(1)):19-28 doi:10.1016/j.nic.2018.09.002.

    PMID: 30466641
  5. 5

    [Optimization of delivering minimum Gd-DTPA at the posterior upper point on tympanic medial wall and hT2W-3D-FLAIR sequence for detecting endolymphatic hydrops].

    Zou J, Wang Z, Chen YK, et al.

    Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery 2018; (53(12)):931-938 doi:10.3760/cma.j.issn.1673-0860.2018.12.011.

    PMID: 30585006
  6. 6

    Laterality of Audiovestibular Symptoms Predicts Laterality of Endolymphatic Hydrops in Hydropic Ear Disease (Menière).

    Gürkov R, Todt I, Jadeed R, et al.

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2020; (41(9)):e1140-e1144 doi:10.1097/MAO.0000000000002775.

    PMID: 32925855
  7. 7

    [Detection and grading of endolymphatic hydrops in Ménière's disease using 3D FLAIR MRI].

    Yan J, Peng L, Cheng H, et al.

    Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery 2015; (29(5)):421-4.

    PMID: 26103661
  8. 8

    MRI With Intratympanic Gadolinium: Comparison Between Otoneurological and Radiological Investigation in Menière's Disease.

    Neri G, Tartaro A, Neri L

    Frontiers in surgery 2021; (8()):672284 doi:10.3389/fsurg.2021.672284.

    PMID: 34169089
  9. 9

    MRI detection of endolymphatic hydrops in Meniere's disease in 8 minutes using MIIRMR and a 20-channel coil after targeted gadolinium delivery.

    Zou J, Wang Z, Chen Y, et al.

    World journal of otorhinolaryngology - head and neck surgery 2019; (5(4)):180-187 doi:10.1016/j.wjorl.2019.04.001.

    PMID: 32083244
  10. 10

    Gadolinium-enhanced delayed MRI of inner ear: A valuable diagnostic tool for Ménière's disease and delayed endolymphatic hydrops: A retrospective cohort study.

    Liu C, Wang Z, Gao W, et al.

    Science progress 2025; (108(4)):368504251382441 doi:10.1177/00368504251382441.

    PMID: 41055935
  11. 11

    Update on Gadolinium-Based Contrast Agent Safety, From the AJR Special Series on Contrast Media.

    Starekova J, Pirasteh A, Reeder SB

    AJR. American journal of roentgenology 2024; (223(3)):e2330036 doi:10.2214/AJR.23.30036.

    PMID: 37850581
  12. 12

    State of Practice: ASNR Statement on Gadolinium-Based Contrast Agent Use in Patients with Chronic Kidney Disease.

    Welker KM, Joyner D, Kam AW, et al.

    AJNR. American journal of neuroradiology 2025; (46(2)):227-230 doi:10.3174/ajnr.A8501.

    PMID: 39284636
  13. 13

    Use of iodinated and gadolinium-based contrast media in patients with chronic kidney disease: Consensus statements from nephrologists, cardiologists, and radiologists at National Taiwan University Hospital.

    Wang KC, Lin LC, Pan SY, et al.

    Journal of the Formosan Medical Association = Taiwan yi zhi 2026; (125(3)):261-267 doi:10.1016/j.jfma.2025.01.019.

    PMID: 39870554
  14. 14

    Incidence and Risk Factors for Gadolinium-Based Contrast Agent Immediate Reactions.

    Costello JR, Kalb B, Martin DR

    Topics in magnetic resonance imaging : TMRI 2016; (25(6)):257-263 doi:10.1097/RMR.0000000000000109.

    PMID: 27748714
  15. 15

    Hypersensitivity reactions to gadolinium-based contrast agents.

    Fok JS, Smith WB

    Current opinion in allergy and clinical immunology 2017; (17(4)):241-246 doi:10.1097/ACI.0000000000000371.

    PMID: 28537933
  16. 16

    First-Trimester Exposure to Gadolinium-based Contrast Agents: A Utilization Study of 4.6 Million U.S. Pregnancies.

    Bird ST, Gelperin K, Sahin L, et al.

    Radiology 2019; (293(1)):193-200 doi:10.1148/radiol.2019190563.

    PMID: 31429682
  17. 17

    Gadolinium-Based Contrast Agents in Pregnant Women: A Literature Review of MRI Safety.

    Alghamdi SA

    Cureus 2023; (15(5)):e38493 doi:10.7759/cureus.38493.

    PMID: 37273372
  18. 18

    Abdominal Imaging in pregnancy (maternal and foetal risks).

    Flanagan E, Bell S

    Best practice & research. Clinical gastroenterology 2020; (44-45()):101664 doi:10.1016/j.bpg.2019.101664.

    PMID: 32359678
  19. 19

    Delayed post gadolinium MRI descriptors for Meniere's disease: a systematic review and meta-analysis.

    Connor S, Grzeda MT, Jamshidi B, et al.

    European radiology 2023; (33(10)):7113-7135 doi:10.1007/s00330-023-09651-8.

    PMID: 37171493
  20. 20

    The "hype" of hydrops in classifying vestibular disorders: a narrative review.

    van der Lubbe MFJA, Vaidyanathan A, Van Rompaey V, et al.

    Journal of neurology 2020; (267(Suppl 1)):197-211 doi:10.1007/s00415-020-10278-8.

    PMID: 33201310
  21. 21

    Magnetic Resonance Imaging of Ménière's Disease After Intravenous Administration of Gadolinium.

    Shi S, Guo P, Wang W

    The Annals of otology, rhinology, and laryngology 2018; (127(11)):777-782 doi:10.1177/0003489418794699.

    PMID: 30156867
  22. 22

    Correlation of endolymphatic hydrops with clinical characteristics in patients with unilateral Ménière's disease.

    Wang Z, Jing Y, Liu CC, et al.

    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2025; (282(10)):5081-5089 doi:10.1007/s00405-025-09430-9.

    PMID: 40307604
  23. 23

    Magnetic resonance imaging and Ménière's disease-unavoidable alliance.

    Sousa R, Raposo F, Guerreiro C, et al.

    Neuroradiology 2021; (63(11)):1749-1763 doi:10.1007/s00234-021-02744-5.

    PMID: 34142211
  24. 24

    Systematic review of magnetic resonance imaging for diagnosis of Meniere disease.

    Lopez-Escamez JA, Attyé A

    Journal of vestibular research : equilibrium & orientation 2019; (29(2-3)):121-129 doi:10.3233/VES-180646.

    PMID: 31356219
  25. 25

    Correlation between magnetic resonance imaging classification of endolymphatic hydrops and clinical manifestations and audiovestibular test results in patients with definite Ménière's disease.

    Jasińska A, Lachowska M, Wnuk E, et al.

    Auris, nasus, larynx 2022; (49(1)):34-45 doi:10.1016/j.anl.2021.03.027.

    PMID: 33865653
  26. 26

    Value of Endolymphatic Hydrops and Perilymph Signal Intensity in Suspected Ménière Disease.

    van Steekelenburg JM, van Weijnen A, de Pont LMH, et al.

    AJNR. American journal of neuroradiology 2020; (41(3)):529-534 doi:10.3174/ajnr.A6410.

    PMID: 32029469

This page is for informational purposes only and does not constitute medical advice. Your radiologist and ENT specialist should advise you about the appropriate scan, contrast, and safety precautions for your medical history.